Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of 3320.HK
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

A very strong day for China Resources Pharmaceutical Group Ltd stock price on Friday
(Updated on May 10, 2024)

Hold candidate since May 09, 2024 Gain 5.56% PDF

The China Resources Pharmaceutical Group Ltd stock price gained 5.56% on the last trading day (Friday, 10th May 2024), rising from HK$5.58 to HK$5.89. During the last trading day the stock fluctuated 6.99% from a day low at HK$5.58 to a day high of HK$5.97. The price has risen in 6 of the last 10 days and is up by 18.75% over the past 2 weeks. Volume fell on the last day by -27 thousand shares and in total, 28 million shares were bought and sold for approximately HK$163.98 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stockhas broken the wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is HK$5.40, a level that may pose a second chance to hit a runner. According to fan-theory HK$6.19 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

3320.HK Signals & Forecast

The China Resources Pharmaceutical Group Ltd stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at HK$5.38 and HK$5.03. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, April 16, 2024, and so far it has risen 26.67%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for China Resources Pharmaceutical Group Ltd stock

On the downside, the stock finds support just below today's level from accumulated volume at HK$5.58 and HK$5.30. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, China Resources Pharmaceutical Group Ltd finds support just below today's level at HK$5.58. If this is broken, then the next support from accumulated volume will be at HK$5.30 and HK$5.08.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved HK$0.390 between high and low, or 6.99%. For the last week, the stock has had daily average volatility of 4.25%.

The China Resources Pharmaceutical Group Ltd stock is extremely overbought on RSI14 (90). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.

Our recommended stop-loss: HK$5.71 (-3.10%) (This stock has medium daily movements and this gives medium risk. The RSI14 is 90 and this increases the risk substantially. There is a buy signal from a pivot bottom found 17 days ago.)

Trading Expectations (3320.HK) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect China Resources Pharmaceutical Group Limited to open at HK$5.81, and during the day (based on 14 day Average True Range), to move between HK$5.71 and HK$6.07, which gives a possible trading interval of +/-HK$0.179 (+/-3.03%) up or down from last closing price. If China Resources Pharmaceutical Group Limited takes out the full calculated possible swing range there will be an estimated 6.06% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ HK$5.58, some HK$0.310 (5.26%) from the current price of HK$5.89, our system finds the risk reward attractive.

Is China Resources Pharmaceutical Group Limited stock A Buy?

China Resources Pharmaceutical Group Ltd holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for China Resources Pharmaceutical Group Limited of Monday, May 13, 2024

Fair opening price May 13, 2024 Current price
HK$5.81 ( 1.30%) HK$5.89

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for 3320.HK

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 6.20 5.32 %
R2 6.05 2.79 %
R1 5.96 1.23 %
Current price: 5.89
Support S1 5.66 -3.83 %
S2 5.57 -5.39 %
S3 5.42 -7.92 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 5.89
Support S1 5.58 -5.26%
S2 5.30 -10.02%
S3 5.08 -13.75%

3320 Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jun 04, 2024 Jun 04, 2024 Jul 19, 2024 HK$0.170 2.88%
2 Jun 05, 2023 Jun 05, 2023 Jun 05, 2023 HK$0.160 2.14%
3 Jun 06, 2022 Jun 06, 2022 Jun 06, 2022 HK$0.150 3.62%
4 Jun 02, 2021 Jun 02, 2021 Jun 02, 2021 HK$0.120 2.21%
5 Jun 29, 2020 Jun 29, 2020 Jun 29, 2020 HK$0.110 2.62%

FAQ

What is the symbol for China Resources Pharmaceutical Group Limited Stock and on which exchange is it traded?
The symbol for China Resources Pharmaceutical Group Limited is 3320.HK and it is traded on the HKEX (Hong Kong Stock Exchange).

Should I buy or sell China Resources Pharmaceutical Group Limited Stock?
China Resources Pharmaceutical Group Ltd holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy China Resources Pharmaceutical Group Limited Stock?
China Resources Pharmaceutical Group Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy China Resources Pharmaceutical Group Limited Stock.

What's the current price of China Resources Pharmaceutical Group Limited Stock?
As of the end of day on the May 10, 2024, the price of an China Resources Pharmaceutical Group Limited (3320.HK) share was HK$5.89.

What is the 52-week high and low for China Resources Pharmaceutical Group Limited Stock?
The 52-week high for China Resources Pharmaceutical Group Limited Stock is HK$8.05 and the 52-week low is HK$4.45.

What is the market capitalization of China Resources Pharmaceutical Group Limited Stock?
As of the May 10, 2024, the market capitalization of China Resources Pharmaceutical Group Limited is 37.004B.

When is the next earnings date for China Resources Pharmaceutical Group Limited?
The upcoming earnings date for China Resources Pharmaceutical Group Limited is Aug 29, 2024.
Click to get the best stock tips daily for free!

About China Resources Pharmaceutical Group Limited

China Resources Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and Hong Kong. The company operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. It offers a range of chemical drugs, Chinese medicines, and biopharmaceutic... 3320.HK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT